Literature DB >> 6372406

Pharmacokinetics and metabolism of deflazacort in the rat, dog, monkey and man.

A Assandri, G Buniva, E Martinelli, A Perazzi, L Zerilli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6372406

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  12 in total

1.  Effects of deflazacort vs. methylprednisone: a randomized study in kidney transplant patients.

Authors:  Jorge R Ferraris; Titania Pasqualini; Guillermo Alonso; Susana Legal; Patricia Sorroche; Ana M Galich; Héctor Jasper
Journal:  Pediatr Nephrol       Date:  2007-02-09       Impact factor: 3.714

2.  Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth.

Authors:  S Balsan; D Stéru; A Bourdeau; R Grimberg; G Lenoir
Journal:  Calcif Tissue Int       Date:  1987-06       Impact factor: 4.333

3.  Deflazacort versus other glucocorticoids: a comparison.

Authors:  Surajit Nayak; Basanti Acharjya
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

Review 4.  Deflazacort. A review of its pharmacological properties and therapeutic efficacy.

Authors:  A Markham; H M Bryson
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

5.  Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone.

Authors:  H Möllmann; G Hochhaus; S Rohatagi; J Barth; H Derendorf
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

Review 6.  Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids.

Authors:  Luca Parente
Journal:  BMC Pharmacol Toxicol       Date:  2017-01-05       Impact factor: 2.483

7.  Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta-analysis of disease progression rates in recent multicenter clinical trials.

Authors:  Craig M McDonald; Gautam Sajeev; Zhiwen Yao; Erin McDonnell; Gary Elfring; Marcio Souza; Stuart W Peltz; Basil T Darras; Perry B Shieh; David A Cox; John Landry; James Signorovitch
Journal:  Muscle Nerve       Date:  2019-11-07       Impact factor: 3.217

8.  In vitro cytochrome P450- and transporter-mediated drug interaction potential of 6β-hydroxy-21-desacetyl deflazacort-A major human metabolite of deflazacort.

Authors:  Jiyuan Ma; Brian Beers; Ravi Manohar; Stephen Roe; Joseph M Colacino; Ronald Kong
Journal:  Pharmacol Res Perspect       Date:  2021-04

Review 9.  Treatment with Synthetic Glucocorticoids and the Hypothalamus-Pituitary-Adrenal Axis.

Authors:  Rosa Maria Paragliola; Giampaolo Papi; Alfredo Pontecorvi; Salvatore Maria Corsello
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

10.  Metabolite V, an epoxide species is a minor circulating metabolite in humans following a single oral dose of deflazacort.

Authors:  Ronald Kong; Jiyuan Ma; Brian Beers; Diksha Kaushik; E Lin; Elizabeth Goodwin; Joseph Colacino; Francesco Bibbiani
Journal:  Pharmacol Res Perspect       Date:  2020-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.